Results 271 to 280 of about 16,330 (302)

Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs

Biochemical Pharmacology, 2000
Ulrich M Zanger, Matthias Schwab
exaly  

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)

Toxicology Letters, 2000
Thomas Kraemer, Frank T Peters, Hans Maurer   +2 more
exaly  

Laser Lights and Designer Drugs: New Techniques for Descending Levels of Mechanisms “in a Single Bound”?

Topics in Cognitive Science, 2020

exaly  

Stability study of the designer drugs “MDA, MDMA and MDEA” in water, serum, whole blood, and urine under various storage temperatures

Forensic Science International, 2001
Jan Van Bocxlaer, André P De Leenheer, A P De Leenheer   +2 more
exaly  

Simultaneous determination of ten amphetamine designer drugs in human whole blood by capillary electrophoresis with diode array detection

Biomedical Chromatography, 2005
Gianpiero Boatto, Maria Nieddu
exaly  

Cross-reactivities of 41 new amphetamine designer drugs to EMIT® immunoassays

Forensic Toxicology, 2012
Gianpiero Boatto, Maria Nieddu, Lucia Burrai   +2 more
exaly  

Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection

Journal of Chromatography A, 2007
Gianpiero Boatto, Maria Nieddu
exaly  

“Not for Human Consumption”: A Review of Emerging Designer Drugs

Pharmacotherapy, 2014
exaly  

Chemical analysis of two new designer drugs: buphedrone and pentedrone

Drug Testing and Analysis, 2012
exaly  

In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH‐SY5Y cells

Journal of Applied Toxicology, 2016
Renata Silva, Carmo H
exaly